Evidence map›Paper›PMID 30413497›Full record

ArticleBMJ open2018

Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK.

Kartini Gadroen, Caitlin N Dodd, Gwen M C Masclee, Maria A J de Ridder, Daniel Weibel, Michael J Mina, Bryan T Grenfell, Miriam C J M Sturkenboom, David A M C van de Vijver, Rik L de Swart

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Measles virus reprograms CD4Frontiers in cell and developmental biology · 2026
    Article
  4. The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Measles immunity and immunosuppression.Current opinion in virology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kartini Gadroen *Department of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
Caitlin N Dodd *Department of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
Gwen M C MascleeDepartment of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
Maria A J de RidderDepartment of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
Daniel WeibelDepartment of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
Michael J MinaDepartment of Pathology, Harvard Medical School, Boston, Massachusetts, USA.
Bryan T GrenfellDepartment of Ecology and Evolutionary Biology, Princeton University, Guyot, New Jersey, USA.
Miriam C J M SturkenboomDepartment of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands.
David A M C van de Vijver *Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.
Rik L de Swart *Department of Viroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0003-3599-8969
Erasmus MC · NLHarvard University · USPrinceton University · US

Funding

Scientific and Technical Computing CoreP2CHD047879 · NICHD · PRINCETON UNIVERSITY · PI SALGANIK, MATTHEW J. · 2014 to 2018
$2.0M
NICHD NIH HHS P2C HD047879
6 · The paper itself

Abstract

objectiveTo test the hypothesis that measles infection increases the incidence of non-measles infectious diseases over a prolonged period of time.

designA population-based matched cohort study. DATA SOURCES: This study examined children aged 1-15 years in The Health Improvement Network UK general practice medical records database. Participants included 2228 patients diagnosed with measles between 1990 and 2014, which were matched on age, sex, general practitioner practice and calendar year with 19 930 children without measles. All controls had received at least one measles vaccination. Children with a history of immune-compromising conditions or with immune-suppressive treatment were excluded. PRIMARY OUTCOME MEASURES: Incidence rate ratio (IRR) of infections, anti-infective prescriptions and all-cause hospitalisations following measles in predetermined periods using multivariate analysis to adjust for confounding variables.

resultsIn children with measles, the incidence rate for non-measles infectious disease was significantly increased in each time period assessed up to 5 years postmeasles: 43% in the first month (IRR: 1.43; 95% CI 1.22 to 1.68), 22% from month one to the first year (IRR: 1.22; 95% CI 1.14 to 1.31), 10% from year 1 to 2.5 years (IRR: 1.10; 95% CI 1.02 to 1.19) and 15% (IRR: 1.15; 95% CI 1.06 to 1.25) in years 2.5 to 5 years of follow-up. Children with measles were more than three times as likely to receive an anti-infective prescription in the first month and 15%-24% more likely between the first month and 5 years. The rate of hospitalisation in children with measles was increased only in the month following diagnosis but not thereafter (IRR: 2.83; 95% CI 1.72 to 4.67).

conclusionFollowing measles, children had increased rates of diagnosed infections, requiring increased prescribing of antimicrobial therapies. This population-based matched cohort study supports the hypothesis that measles has a prolonged impact on host resistance to non-measles infectious diseases.

Indexed as

Immunosuppression TherapyAdolescentAnti-Infective AgentsCase-Control StudiesChildChild, PreschoolCommunicable DiseasesDatabases, FactualFemaleHospitalizationHumansImmunologic MemoryIncidenceInfantLongitudinal StudiesMaleAnti-Infective AgentsMeasles Vaccineimmune suppressionmeasles

Identifiers

PMID30413497
PMCPMC6231568
OpenAlexW2900279837

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.